戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ontyphoidal Salmonella species, and Yersinia enterocolitica.
2 adA) is a major virulence factor of Yersinia enterocolitica.
3 e membrane topologies of PspB and PspC in Y. enterocolitica.
4 wing either i.p. or i.v. inoculation with Y. enterocolitica.
5 extensively in Escherichia coli and Yersinia enterocolitica.
6 tive immunity against Gram-negative Yersinia enterocolitica.
7 against the Gram-negative bacterium Yersinia enterocolitica.
8 riaceae, such as the enteropathogen Yersinia enterocolitica.
9 type III secretion system (T3SS) of Yersinia enterocolitica.
10 tive signal transduction pathway in Yersinia enterocolitica.
11   An aspirate from the axillary mass grew Y. enterocolitica.
12 es using the gastroenteric pathogen Yersinia enterocolitica.
13 ted with the AHL-producing pathogen Yersinia enterocolitica.
14 AHLs to mimic a constant interaction with Y. enterocolitica.
15  in naive macrophages infected with Yersinia enterocolitica.
16 n of FtsQ from Escherichia coli and Yersinia enterocolitica.
17 nes in response to S. typhimurium but not Y. enterocolitica.
18  response to prolonged secretin stress in Y. enterocolitica.
19 s susceptible to the enteropathogen Yersinia enterocolitica.
20 transmission for the enteropathogen Yersinia enterocolitica.
21 o alleviate transcriptional repression in Y. enterocolitica.
22 N-acylhomoserine lactone (AHL) profile of Y. enterocolitica.
23 y and specifically to the inv promoter of Y. enterocolitica.
24 ric lymph nodes after oral infection with Y. enterocolitica.
25 tive regulators of psp gene expression in Y. enterocolitica.
26 intestinal lymphatic tissue infected with Y. enterocolitica.
27  for the existence of three subspecies of Y. enterocolitica.
28 s, Yersinia pseudotuberculosis, and Yersinia enterocolitica.
29 se (LD(50)) following oral infection with Y. enterocolitica.
30 o intravenous (i.v.) infection with Yersinia enterocolitica.
31 role of the Ysps during the life cycle of Y. enterocolitica.
32 es, Yersinia pseudotuberculosis and Yersinia enterocolitica.
33 ssed by Yersinia pestis, but not by Yersinia enterocolitica.
34 compared to those infected with wild-type Y. enterocolitica.
35 ric infection by the proteobacteria Yersinia enterocolitica.
36  mg/L respectively) were observed against Y. enterocolitica.
37 ellin of Salmonella Typhimurium and Yersinia enterocolitica.
38 lague, Yersinia pseudotuberculosis, Yersinia enterocolitica.
39 y informative typing scheme available for Y. enterocolitica.
40 to reverse the uptake blockade imposed by Y. enterocolitica.
41 istant to orogastric infection with Yersinia enterocolitica.
42  spontaneously arising pathogenic Ab with Y. enterocolitica.
43 coccus aureus, Escherichia coli and Yersinia enterocolitica.
44 OmpC, and OmpF confirming reactivity with Y. enterocolitica.
45 thogenesis, including the bacterium Yersinia enterocolitica.
46 illus cereus, Escherichia coli, and Yersinia enterocolitica.
47 teins at their endogenous levels in Yersinia enterocolitica.
48 dA, which is the primary C4BP receptor of Y. enterocolitica.
49 omonas sp. (23.8%) by FilmArray and Yersinia enterocolitica (48.1%) by the Luminex assay.
50 t in all 47 low-pathogenicity strains and Y. enterocolitica 8081 but absent from all nonpathogenic 1A
51  (99.4 to 99.8), and 0.96 (0.93 to 0.99); Y. enterocolitica, 99.0% (94.8 to 99.8), 99.9% (99.8 to 99.
52                                        In Y. enterocolitica, a rovA mutant is attenuated for virulenc
53 obacter jejuni), Shigella flexneri, Yersinia enterocolitica, adenovirus, and Strongyloides fulleborni
54 t that EmaA is an orthologue of the Yersinia enterocolitica adhesin YadA.
55 limatization of the psychrotolerant Yersinia enterocolitica after a cold shock from 30 degrees C to 1
56 , we engineered EHEC to express the Yersinia enterocolitica AHL synthase gene yenI, which constitutiv
57     We find that IECs infected with Yersinia enterocolitica, an enteric pathogen, use beta1 integrins
58                                     Yersinia enterocolitica, an important cause of human gastroenteri
59 gellar type III secretion system of Yersinia enterocolitica and a phospholipase reporter (yplA).
60 ive clearance of the ileal pathogen Yersinia enterocolitica and an elevated inflammatory cytokine res
61 PspC destabilization is conserved between Y. enterocolitica and E. coli.
62 fore, we investigated the role of ArcB in Y. enterocolitica and E. coli.
63 sis while negatively regulated by YmoA in Y. enterocolitica and H-NS in Y. pseudotuberculosis.
64 e translocator domains of YadA from Yersinia enterocolitica and Hia from Haemophilus influenzae.
65 antipathogenic effects in the gut against Y. enterocolitica and highlight the need to investigate the
66 l)-l-homoserine lactone (3-oxo-C6-HSL) in Y. enterocolitica and inhibit QS-associated biofilm maturat
67 secretes (Yops), prevents phagocytosis of Y. enterocolitica and is required for disease processes in
68 e Yop secretion protein (Ysc) M2 of Yersinia enterocolitica and LcrQ of Y. pestis, formerly described
69 higella spp., Campylobacter spp. or Yersinia enterocolitica and matched each with up to 4 unexposed s
70                                     Yersinia enterocolitica and related bacteria with a defective Psp
71             The in situ structures of the Y. enterocolitica and S. flexneri injectisomes had similar
72                   Escherichia coli, Yersinia enterocolitica and Salmonella enterica serovar Typhimuri
73  response required for virulence in Yersinia enterocolitica and Salmonella enterica.
74 irst three-dimensional structure of Yersinia enterocolitica and Shigella flexneri injectisomes in sit
75 cylhomoserine lactones (AHLs) produced by Y. enterocolitica and upregulates the expression of an inva
76 ttle overlap between the RovA regulons of Y. enterocolitica and Y. pestis despite the fact that RovA
77 actors Vn and C4BP, and Ail homologs from Y. enterocolitica and Y. pseudotuberculosis recruit factor
78 ediates the transcription of inv in Yersinia enterocolitica and Y. pseudotuberculosis.
79 erved mechanism of inv regulation between Y. enterocolitica and Y. pseudotuberculosis.
80  are conserved in Yersinia, divergence of Y. enterocolitica and Y. pseudotuberculosis/Y. pestis durin
81 ences between Yersinia enterocolitica subsp. enterocolitica and Yersinia enterocolitica subsp. palear
82 h is positively regulated by RovA in both Y. enterocolitica and Yersinia pseudotuberculosis while neg
83 jor adhesion and invasion factor in Yersinia enterocolitica and Yersinia pseudotuberculosis.
84 nce method was 1.2% ETEC, 0.1% Vibrio, 0% Y. enterocolitica, and 0% P. shigelloides Compared to the r
85  identified the Salmonella species, Yersinia enterocolitica, and Campylobacter species but failed to
86 mon food pathogens, including E. coli and Y. enterocolitica, and could even detect Salmonella spp. fr
87 ethods for the detection of ETEC, Vibrio, Y. enterocolitica, and P. shigelloides in stool specimens f
88 10-fold higher than that of the wild-type Y. enterocolitica, and there are significant inflammatory r
89 , E. coli O157:H7, Vibrio cholerae, Yersinia enterocolitica, and toxigenic Clostridium difficile), pa
90 he pathogenic Yersiniae (Yersinia pestis, Y. enterocolitica, and Y. pseudotuberculosis).
91  this study we show that PspB and PspC of Y. enterocolitica are dual function proteins, acting both a
92 ar Typhimurium (S. typhimurium) and Yersinia enterocolitica are enteric pathogens capable of colonizi
93  spectroscopy, we show that in live Yersinia enterocolitica bacteria these soluble proteins form comp
94      We also show that RovA and H-NS from Y. enterocolitica bind to a similar region of the inv promo
95                                           Y. enterocolitica biovar 1B additionally has a distinct chr
96                                     Yersinia enterocolitica biovar 1B contains two type III secretion
97                                     Yersinia enterocolitica biovar 1B employs two type three secretio
98                                     Yersinia enterocolitica biovar 1B maintains three distinct type I
99                   Full virulence of Yersinia enterocolitica Biovar 1B requires two distinct and dista
100 rally dynamic gene expression patterns of Y. enterocolitica biovar 1B through the course of an in vit
101  opened with the discovery of the Ysps of Y. enterocolitica Biovar 1B, which are translocated into ho
102                 FtsH destabilizes PspC in Y. enterocolitica, but coproduction of PspC with its bindin
103 when YspP was constitutively expressed in Y. enterocolitica bv.
104 ances gastrointestinal infection by Yersinia enterocolitica bv. 1B.
105 dritic cells, and a yopP mutant of a live Y. enterocolitica carrier vaccine elicited effective primin
106                                     Yersinia enterocolitica causes a severe enteric infection in infa
107                      Infection with Yersinia enterocolitica causes acute diarrhea in early childhood.
108                                     Yersinia enterocolitica causes an estimated 116,716 illnesses ann
109                                     Yersinia enterocolitica causes human gastroenteritis, and many is
110                                     After Y. enterocolitica challenge, YopB/LcrV+dmLT-vaccinated mice
111 es to protect against an otherwise lethal Y. enterocolitica challenge.
112 ytxAB genes are not closely linked in the Y. enterocolitica chromosome, and whereas ytxR is present i
113 curring in response to S. typhimurium and Y. enterocolitica colonization of PP using Affymetrix GeneC
114 ate a diverse collection of 94 strains of Y. enterocolitica consisting of 35 human, 35 pig, 15 sheep,
115        These results reveal facets of how Y. enterocolitica controls the function of the Ysa TTS syst
116      The enteropathogenic bacterium Yersinia enterocolitica deactivates TLR-induced signaling pathway
117 coccus aureus, Escherichia coli and Yersinia enterocolitica--demonstrated that the zone of inhibition
118 n that a number of RovA-regulated loci in Y. enterocolitica do not have orthologues in Y. pestis and
119 few intestinal pathogens, including Yersinia enterocolitica, do produce acyl-HSLs, and Salmonella can
120            Further analysis revealed that Y. enterocolitica does not cluster according to source (hos
121    These findings add a new aspect of how Y. enterocolitica effectively evades the host complement sy
122 retion system of the human pathogen Yersinia enterocolitica enabled efficient identification of secre
123 irus, rotavirus A, Vibrio cholerae, Yersinia enterocolitica, Entamoeba histolytica, Cryptosporidium s
124 spp., Vibrio spp., Vibrio cholerae, Yersinia enterocolitica, enteroaggregative E. coli, enteropathoge
125 tool specimens for the detection of Yersinia enterocolitica, enterotoxigenic Escherichia coli (ETEC),
126               After i.p. inoculation with Y. enterocolitica, fibrinogen-deficient mice display impair
127                                  However, Y. enterocolitica had no effect on S. Typhimurium uptake by
128 udotuberculosis and Y. pestis and YopP in Y. enterocolitica has been shown to regulate host immune re
129                                     Yersinia enterocolitica has three type three secretion systems, t
130  in the genomes of E. coli O157:H7, Yersinia enterocolitica, Helicobacter pylori, and Vibrio cholerae
131 a does detect the AHL production of Yersinia enterocolitica in mouse Peyer's patches.
132 al the complete set of genes expressed by Y. enterocolitica in response to infection and provide the
133                               Even though Y. enterocolitica induces a robust inflammatory response du
134 ro FTY720 treatment downregulated CCR7 on Y. enterocolitica-infected bone marrow-derived DCs and puri
135 NF-Y increases Yop translocation in Yersinia enterocolitica-infected cells up to 5-fold.
136          Fingolimod (FTY720) treatment of Y. enterocolitica-infected mice reduced the CD11b(-) subset
137 D103(+)CD11b(+)) were found in the RLN of Y. enterocolitica-infected TNFRp55(-/-) mice.
138                           On day 14 after Y. enterocolitica infection (arthritis onset), we found tha
139                              During Yersinia enterocolitica infection CD4+ cells are the source of de
140  inflammatory cytokines in the control of Y. enterocolitica infection in IL-6(-/-) mice was undertake
141 ribed here compare oral S. typhimurium or Y. enterocolitica infection in stromelysin-1 (MMP-3)-defici
142  A striking feature of the pathology of a Y. enterocolitica infection is inflammation.
143 rant acute inflammatory response to Yersinia enterocolitica infection leads to long-lasting shifts in
144                 One role of IL-6 during a Y. enterocolitica infection may be the downmodulation of th
145                                           Y. enterocolitica infection promoted the development of ant
146  Establishment of S2 cells as a model for Y. enterocolitica infection provides a versatile tool to el
147 of 7-day-old and adult mice to orogastric Y. enterocolitica infection were assessed in 50% lethal dos
148 nt secretion of IL-8 in response to Yersinia enterocolitica infection were dependent on extracellular
149 (1) receptor is important for controlling Y. enterocolitica infection within the Peyer's patches and
150 -6 plays an anti-inflammatory role during Y. enterocolitica infection, and in other systems IL-6 has
151 LT achieved 60% protection against lethal Y. enterocolitica infection, and vaccine efficacy increased
152 g protective roles for CD4 T cells during Y. enterocolitica infection, vaccinating mice with a 16-ami
153 y to activate innate immunity after Yersinia enterocolitica infection.
154 ion of gut inflammation characteristic of Y. enterocolitica infection.
155 for protection of neonates during primary Y. enterocolitica infection.
156 significantly up-regulated in response to Y. enterocolitica infection.
157  intestinal inflammation in response to a Y. enterocolitica infection.
158 l model for studying the host response to Y. enterocolitica infection.
159 stics previously described following i.v. Y. enterocolitica infection.
160 ory role of this endogenous lectin during Y. enterocolitica infection.
161 exhibited higher expression of CCR7 after Y. enterocolitica infection.
162                                           Y. enterocolitica infections in FoodNet sites have signific
163              From 1996 through 2009, 2085 Y. enterocolitica infections were reported to FoodNet.
164 ive surveillance for laboratory-confirmed Y. enterocolitica infections, defined as the isolation of Y
165                   These data suggest that Y. enterocolitica inhibits intracellular pre-IL-1alpha sign
166 SA (via an IC intermediate) as does Yersinia enterocolitica Irp9.
167                                     Yersinia enterocolitica is a food-borne pathogen that preferentia
168                                     Yersinia enterocolitica is a gram-negative enteric pathogen respo
169 hanisms in which the enteropathogen Yersinia enterocolitica is able to disseminate from the lumen of
170                                     Yersinia enterocolitica is able to efficiently invade Peyer's pat
171                                     Yersinia enterocolitica is an enteric pathogen capable of causing
172                                     Yersinia enterocolitica is an enteropathogenic bacterium that cau
173                         We show here that Y. enterocolitica is capable of infecting S2 cells and repl
174 The salicylate synthase, Irp9, from Yersinia enterocolitica is involved in the biosynthesis of the si
175                          However, because Y. enterocolitica is typically a food-borne pathogen, the o
176                                     Yersinia enterocolitica is typically considered an extracellular
177 Escherichia coli (EHEC) isolates, 2 Yersinia enterocolitica isolates, 2 Campylobacter species, and 23
178                                           Y. enterocolitica lacking the virulence plasmid failed to i
179 as prevented when mice were infected with Y. enterocolitica lacking YopP or YopH, two critical effect
180  neonatal mice with low doses of virulent Y. enterocolitica leads to vigorous intestinal and systemic
181 ified a new positive regulator of rovA in Y. enterocolitica, LeuO.
182 oan (Toxoplasma gondii), bacterial (Yersinia enterocolitica, Listeria monocytogenes, and Mycobacteriu
183                                 The Yersinia enterocolitica LuxI homologue YenI directs the synthesis
184               Pathogenic biovars of Yersinia enterocolitica maintain the well-studied plasmid-encoded
185                                           Y. enterocolitica mutants lacking either the Ysa or Ysc T3S
186 4, 8%), norovirus (n = 14, 8%), and Yersinia enterocolitica (n = 7, 4%).
187 =14, 8%), norovirus (n=14, 8%), and Yersinia enterocolitica (n=7, 4%).
188 osa and joints in a murine model of Yersinia enterocolitica O:3-induced reactive arthritis (ReA) in T
189 on-ready tetrasaccharide of O-PS of Yersinia enterocolitica O:50 strain 3229 and the trisaccharide of
190 s KIM D27 LcrV (LcrV(D27)) bind LcrV from Y. enterocolitica O:9 strain W22703 (LcrV(W22703)) or O:8 s
191 no effect on extracellular nonsiderophilic Y enterocolitica O8 or Staphylococcus aureus Hepcidin anal
192 derophilic extracellular pathogens (Yersinia enterocolitica O9) by controlling non-transferrin-bound
193                 Mutating all CSC-boxes in Y. enterocolitica of a plasmid bound cspA1/A2 dramatically
194 t interactions between S. Typhimurium and Y. enterocolitica or that the SdiA regulon members do not f
195 a infections, defined as the isolation of Y. enterocolitica or unspeciated Yersinia from a human clin
196 modest (10-30%) protection against lethal Y. enterocolitica oral infection.
197                                           Y. enterocolitica organisms were more virulent in the IL-6(
198  a regulatory role for this lectin during Y. enterocolitica pathogenesis, mice lacking Gal-1 showed i
199 ressed in mucosal tissues, contributes to Y. enterocolitica pathogenicity by undermining protective a
200 2 recombined with a close relative of the Y. enterocolitica phage phiYeO3-12 to yield progeny phages,
201                                 The Yersinia enterocolitica phage shock protein (Psp) stress response
202                                 The Yersinia enterocolitica phage shock protein (Psp) system is induc
203                                 The Yersinia enterocolitica phage-shock-protein (Psp) stress response
204 e early precursor B cells are expanded by Y. enterocolitica porins to undergo somatic hypermutation t
205 ngle factor mediating serum resistance of Y. enterocolitica, presumably by binding C4b binding protei
206 (A) modified with C16:0 predominated, and Y. enterocolitica produced a unique tetra-acylated lipid A.
207        The mammalian enteropathogen Yersinia enterocolitica produces two main N-acylhomoserine lacton
208 -NS and RovA bind is not conserved in the Y. enterocolitica promoter.
209 rall, these studies support the idea that Y. enterocolitica promotes the development of highly inflam
210 ologues but is not conserved in the Yersinia enterocolitica protein.
211 The role of microbial Ags was tested with Y. enterocolitica proteins.
212                                       The Y. enterocolitica psp locus is made up of two divergently t
213                                     Yersinia enterocolitica psp mutants cannot grow when the secretin
214 ore, PspG is the missing component of the Y. enterocolitica Psp regulon that was previously predicted
215 e proteins involved in inducing the Yersinia enterocolitica Psp stress response.
216 tudy addressed these issues for the Yersinia enterocolitica Psp system.
217         We also compared induction of the Y. enterocolitica Psp, RpoE, and Cpx responses.
218              Previously, we reported that Y. enterocolitica PspB functions to positively control the
219 dence that it is the C-terminal domain of Y. enterocolitica PspC (PspC(CT)) that interacts directly w
220                                       The Y. enterocolitica pspG gene was identified because its prom
221                            In adult mice, Y. enterocolitica rapidly disseminated to the spleen and li
222                                     Yersinia enterocolitica rarely causes extraintestinal disease.
223           Enteric pathogens such as Yersinia enterocolitica readily colonize and induce disease withi
224 dent and distantly related TTS systems of Y. enterocolitica recognize protein substrates by a similar
225                                           Y. enterocolitica reduces S. Typhimurium invasion of HeLa a
226 ion with the model enteric pathogen Yersinia enterocolitica reduces the mean time to death by 1 day (
227       The YenR and YenI proteins of Yersinia enterocolitica resemble the quorum sensing proteins LuxR
228 ogenous chromosomally encoded proteins in Y. enterocolitica revealed discrete complexes corresponding
229         Analysis of the core gene set for Y. enterocolitica revealed that 20.8% of the genes were sha
230 protein reporters, we determined that the Y. enterocolitica rovA (rovA(Yent)) promoter is weaker than
231                                         A Y. enterocolitica rovA mutant has a significant decrease in
232  In Yersinia pseudotuberculosis and Yersinia enterocolitica, RovA regulates expression of the invasio
233                           Furthermore, in Y. enterocolitica RovM only in the presence of Hfq affected
234 raphy to solve the structure of the Yersinia enterocolitica RsmA homologue.
235 he rfaH genes from Vibrio cholerae, Yersinia enterocolitica, S. enterica serovar Typhimurium, and Kle
236  in the physiology and virulence of Yersinia enterocolitica serotype O:3.
237 ches of mice infected orogastrically with Y. enterocolitica serotype O:8 compared with noninfected ho
238 the lipopolysaccharide O-antigen of Yersinia enterocolitica serovars O:5/O:5,27.
239 Sequence analysis of the JB580v strain of Y. enterocolitica shows that, due to a premature stop codon
240 pestis) was obtained with 1 (of 10) Yersinia enterocolitica strains and 2 (of 10) Yersinia pseudotube
241  cannot block type III injection by Yersinia enterocolitica strains and suggested that lcrV polymorph
242        Infection of eukaryotic cells with Y. enterocolitica strains expressing a Ysp-CyaA chimeric pr
243               The highly pathogenic Yersinia enterocolitica strains have a chromosomally encoded type
244 unable to block the type III injection of Y. enterocolitica strains, expression of lcrV(W22703) or lc
245 ise unable to block type III injection by Y. enterocolitica strains.
246 tained using two different high-virulence Y. enterocolitica strains.
247 ss, the ytxAB genes are conserved in many Y. enterocolitica strains.
248 ia species, and differences between Yersinia enterocolitica subsp. enterocolitica and Yersinia entero
249 ocolitica subsp. enterocolitica and Yersinia enterocolitica subsp. palearctica.
250 m is primarily an intracellular pathogen, Y. enterocolitica survives primarily extracellularly.
251 t the RovA regulon may be dispensable for Y. enterocolitica systemic disease and inflammatory respons
252 s maltophilia, Vibrio cholerae, and Yersinia enterocolitica T2S-expressing plant pathogens include Di
253 d to the N-terminal fragment of the Yersinia enterocolitica T3S substrate YopE, are effectively deliv
254 slocation of TARP by a heterologous Yersinia enterocolitica T3SS.
255                                           Y. enterocolitica tends to persist in soil for long periods
256 ction, C57BL/6 mice are more resistant to Y. enterocolitica than are BALB/c mice.
257 rough mice infected with a yenI mutant of Y. enterocolitica that cannot synthesize AHLs.
258 nic Yersinia pseudotuberculosis and Yersinia enterocolitica) that mediate a low-calcium response.
259 CSC-box into a plasmid-bound lacZ gene in Y. enterocolitica, the mRNA of this construct was cleaved w
260 the Ysa TTS system impacts the ability of Y. enterocolitica to colonize gastrointestinal tissues.
261   In this study, we tested the ability of Y. enterocolitica to modulate intracellular IL-1alpha-depen
262  important human-pathogenic species Yersinia enterocolitica to whole-genome resolution levels.
263                                     Yersinia enterocolitica transports YscM1 and YscM2 via the type I
264                                     Yersinia enterocolitica type III secretion machines transport Yop
265    To subvert the host's immune response, Y. enterocolitica uses a type III secretion system consisti
266                                     Yersinia enterocolitica uses type III secretion to transport Yop
267 en linked to robust phenotypes, including Y. enterocolitica virulence.
268 otein (Psp) system is essential for Yersinia enterocolitica virulence.
269                    yopR variants of Yersinia enterocolitica W22703 displayed a reduced ability to inj
270  screened transposon insertion mutants of Y. enterocolitica W22703 for defects in type III secretion
271 n against lethal oral infections by Yersinia enterocolitica WA and Y. pseudotuberculosis PB1+.
272                                           Y. enterocolitica was also able to inhibit the invasion of
273 s cereus was the most sensitive and Yersinia enterocolitica was found to be the most resistant.
274                                           Y. enterocolitica was present within the murine mucosa of b
275 he bacteria to colonize neonatal tissues; Y. enterocolitica was readily detectable in the intestine a
276 -coil adhesin homologous to YadA of Yersinia enterocolitica, was hypothesized to mediate the interact
277 ical properties of YscN and YscL of Yersinia enterocolitica, we have characterized them as the ATPase
278 to host cell uptake of S. Typhimurium and Y. enterocolitica, we investigated how each pathogen influe
279                               Using Yersinia enterocolitica, we show that oral infection promotes T(H
280 responses elicited in neonates exposed to Y. enterocolitica were associated with long-term protection
281 val of MMP-3-deficient mice infected with Y. enterocolitica when compared with littermate controls.
282 a Gram-negative bacterial pathogen, Yersinia enterocolitica, when subjected to low temperature and se
283  coli, Salmonella enterica and also Yersinia enterocolitica, where it is essential for virulence.
284 yopP-deficient strain than with wild-type Y. enterocolitica, whereas only modest increases occurred i
285 osed of ~22 copies of SctQ (YscQ in Yersinia enterocolitica), which require the presence of YscQC, th
286 a marcescens, Escherichia coli, and Yersinia enterocolitica, which have some similarities in their MA
287 mon to three pathogenic Yersinia species: Y. enterocolitica, Y. pseudotuberculosis, and Y. pestis.
288 ilus influenzae Hia adhesin and the Yersinia enterocolitica YadA adhesin.
289 g model of factor H to YadA and show that Y. enterocolitica YadA recruits C3b and iC3b directly, with
290 rsinia pseudotuberculosis (Ypt) and Yersinia enterocolitica (Ye), as well as the causative agent of p
291                                      In a Y. enterocolitica yenI mutant, swimming motility is tempora
292 ivity, we have characterized the OGL from Y. enterocolitica, YeOGL, on oligogalacturonides and determ
293    The type III secretion signal of Yersinia enterocolitica YopN was mapped using a gene fusion appro
294    We report the MgADP structure of Yersinia enterocolitica YopO in complex with actin, which reveals
295                                 The Yersinia enterocolitica ysa T3SS is activated in response to NaCl
296                                 The Yersinia enterocolitica Ysa T3SS is such a system, where the appa
297 Using a genetic approach, a collection of Y. enterocolitica Ysa TTS mutants was generated by mutagene
298 osttranscriptional gene regulation, Yersinia enterocolitica yscM1 and yscM2 as well as Yersinia pesti
299 regulator that controls expression of the Y. enterocolitica ytxAB genes.
300                                 The Yersinia enterocolitica YtxR protein is a LysR-type transcription

 
Page Top